Chemokine and Protein Patterns in RSV Infection

RSV 感染中的趋化因子和蛋白质模式

基本信息

项目摘要

Respiratory Syncytial Virus (RSV) infections have been uniquely linked to the development and the severity of asthma. Virus-specific cellular immunity, particularly the CTL response, is implicated in the immunopathogenesis of RSV infection. We have shown that nasopharyngeal concentrations of MIP-1alpha, a prototype of viral-inducible airway epithelial chemokines, correlate with the degree of illness severity in RSV-infected children and that mice genetically deficient in MIP-1 alpha (-/-) have a striking reduction in lung inflammation. We hypothesize that MIP-alpha, by virtue of its activity on both NK cells and CTL, functions as a bridge between innate and adaptive immunity to RSV, thus playing a crucial role in restricting viral replication, yet inducing mucosal inflammation, wheezing and airway hyperresponsiveness (AHR). In this project we propose the following aims: 1. Identify the contribution of MIP-1 alpha in the control of viral replication and development of RSV-induced lung inflammation, AHR and illness. Using MIP-1alpha -/- mice, we will test the hypothesis that MIP-let expression is necessary for viral clearance, but also linked to the pathogenesis of AHR and clinical illness in RSV infections. 2. Investigate the requirement of MIP-1 et for the migration and activation of NK cells and NK-cell driven CTL responses in RSV infection. We will test whether MIP-1alpha promotes NK cell migration to the lung, activation, and antiviral function and whether it regulates NK-dependent RSV-specific CTL responses. 3. Analyze the spectrum of RSV-inducible proteins in the lung of mice, either control or MIP-1 alpha deficient, using a high-throughput proteomics approach with 2D SDS-PAGE and MALDI-TOF mass spectroscopy. We will generate databases of lung proteins from RSV-infected mice to identify downstream proteins/mediators affected by MIP-let-dependent pathways. 4. Analyze whether distinct protein patterns at the airway mucosal site can discriminate between infants with different severity of illness or degree of chemokine response following naturally-acquired RSV infection. By the high-throughput proteomics approach we will identify specific proteins or protein patterns in nasopharyngeal secretions that may contribute to the pathogenesis or severity of RSV-induced disease, and are associated with greater production of MIP-1alpha or other epithelial-derived chemokines. These studies will contribute to the identification of new strategies to promptly recognize, prevent, or early treat the most severe clinical forms of RSV infection in infancy, thus reducing the long-term burden of recurrent wheezing and asthma.
呼吸道合胞病毒(RSV)感染与哮喘的发生和严重程度有独特的联系。病毒特异性细胞免疫,特别是CTL反应,与RSV感染的免疫发病机制有关。我们已经证明,鼻咽中MIP-1α的浓度与RSV感染儿童的疾病严重程度相关,MIP-1α是病毒诱导的呼吸道上皮趋化因子的原型,并且MIP-1α(-/-)基因缺陷的小鼠的肺部炎症显著减少。我们推测,MIP-α通过其在NK细胞和CTL上的活性,在RSV天然免疫和获得性免疫之间发挥桥梁作用,从而在限制病毒复制、诱导粘膜炎症、喘息和呼吸道高反应性(AHR)方面发挥关键作用。在本项目中,我们提出了以下目标:1.确定MIP-1α在控制RSV诱导的肺部炎症、AHR和疾病的病毒复制和发展中的作用。利用MIP-1α/-小鼠,我们将检验这一假设,即MIP-let的表达对于病毒清除是必要的,但也与呼吸道合胞病毒感染的AHR和临床疾病的发病机制有关。2.探讨呼吸道合胞病毒感染时MIP-1 ET对NK细胞迁移和激活及NK细胞驱动的CTL反应的要求。我们将测试MIP-1α是否促进NK细胞向肺的迁移、激活和抗病毒功能,以及它是否调节NK依赖的RSV特异性CTL反应。3.分析呼吸道合胞病毒诱导的蛋白质谱 利用高通量蛋白质组学方法,结合2D SDS-PAGE和MALDI-TOF质谱学,对对照或MIP-1α缺陷小鼠的肺组织进行了研究。我们将建立RSV感染小鼠的肺蛋白质数据库,以确定受MIP-let依赖通路影响的下游蛋白质/介质。4.分析呼吸道粘膜部位不同的蛋白质模式是否可以区分自然获得的RSV感染后不同疾病严重程度或趋化因子反应程度的婴儿。通过高吞吐量 蛋白质组学方法我们将在鼻咽分泌物中确定特定的蛋白质或蛋白质模式,这些蛋白质或蛋白质模式可能与RSV诱导的疾病的发病或严重程度有关,并与更多的MIP-1α或其他上皮来源的趋化因子的产生有关。这些研究将有助于确定新的战略,迅速识别、预防或早期治疗婴儿时期最严重的呼吸道合胞病毒感染临床形式,从而减少反复发作的喘息和哮喘的长期负担。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Roberto P Garofalo其他文献

Expression, Regulation and Function of the Costimulatory Molecules B7-1(CD80) and B7-2 (CD86) and MHC Class II on Human Enterocytes † 30
  • DOI:
    10.1203/00006450-199804001-00051
  • 发表时间:
    1998-04-01
  • 期刊:
  • 影响因子:
    3.100
  • 作者:
    Tetsuro Kitamura;Gang Ye;Todd F Elliott;Pearay L Ogra;Victor E Reyes;Roberto P Garofalo
  • 通讯作者:
    Roberto P Garofalo
MyPEEPS Mobile App for HIV Prevention Among Transmasculine Youth: Adaptation Through Community-Based Feedback and Usability Evaluation
用于跨男性青少年艾滋病毒预防的 MyPEEPS 移动应用程序:通过基于社区的反馈和可用性评估进行调整
  • DOI:
    10.2196/56561
  • 发表时间:
    2024
  • 期刊:
  • 影响因子:
    2.2
  • 作者:
    Dorcas Adedoja;L. Kuhns;Asa Radix;Roberto P Garofalo;Maeve Brin;Rebecca Schnall
  • 通讯作者:
    Rebecca Schnall
Demonstration of a Novel IgA Receptor on Intestinal Epithelial Cells • 29
肠上皮细胞新型 IgA 受体的展示 • 29
  • DOI:
    10.1203/00006450-199804001-00050
  • 发表时间:
    1998-04-01
  • 期刊:
  • 影响因子:
    3.100
  • 作者:
    Tetsuro Kitamura;Roberto P Garofalo;Dianne K Hammond;Kiyonori Kuki;Mohan Shenoy;Antonella Casola;Pearay L Ogra;Randall M Goldblum
  • 通讯作者:
    Randall M Goldblum
REGULATION OF EOSINOPHIL FUNCTION BY RESPIRATORY SYNCYTIAL VIRUS-INFECTED AIRWAY EPITHELIAL CELLS † 703
呼吸道合胞病毒感染的气道上皮细胞对嗜酸性粒细胞功能的调节 † 703
  • DOI:
    10.1203/00006450-199704001-00723
  • 发表时间:
    1997-04-01
  • 期刊:
  • 影响因子:
    3.100
  • 作者:
    Roberto P Garofalo;Barbara Olszeska-Pazdrak;Pearay L Ogra
  • 通讯作者:
    Pearay L Ogra

Roberto P Garofalo的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Roberto P Garofalo', 18)}}的其他基金

Role of the endogenous gasotransmitter H2S in ETS-mediated airway disease
内源性气体递质 H2S 在 ETS 介导的气道疾病中的作用
  • 批准号:
    9093199
  • 财政年份:
    2016
  • 资助金额:
    $ 22.09万
  • 项目类别:
Role of the endogenous gasotransmitter H2S in ETS-mediated airway disease
内源性气体递质 H2S 在 ETS 介导的气道疾病中的作用
  • 批准号:
    9272402
  • 财政年份:
    2016
  • 资助金额:
    $ 22.09万
  • 项目类别:
Antiviral Innate Pathways and Superoxide Dismutase in RSV Bronchiolitis
RSV 毛细支气管炎中的抗病毒先天途径和超氧化物歧化酶
  • 批准号:
    8621088
  • 财政年份:
    2013
  • 资助金额:
    $ 22.09万
  • 项目类别:
Antiviral Innate Pathways and Superoxide Dismutase in RSV Bronchiolitis
RSV 毛细支气管炎中的抗病毒先天途径和超氧化物歧化酶
  • 批准号:
    8779708
  • 财政年份:
    2013
  • 资助金额:
    $ 22.09万
  • 项目类别:
Chemokine and Protein Patterns in RSV Infection
RSV 感染中的趋化因子和蛋白质模式
  • 批准号:
    8134693
  • 财政年份:
    2010
  • 资助金额:
    $ 22.09万
  • 项目类别:
Tissue Culture and Immunoassay
组织培养和免疫测定
  • 批准号:
    8134697
  • 财政年份:
    2010
  • 资助金额:
    $ 22.09万
  • 项目类别:
CORE--Tissue Culture and Immunoassay
核心——组织培养和免疫分析
  • 批准号:
    7392741
  • 财政年份:
    2007
  • 资助金额:
    $ 22.09万
  • 项目类别:
Chemokine and Protein Patterns in RSV Infection
RSV 感染中的趋化因子和蛋白质模式
  • 批准号:
    6878399
  • 财政年份:
    2004
  • 资助金额:
    $ 22.09万
  • 项目类别:
Infant Bronchiolitis and Viral Core (IBVC)
婴儿细支气管炎和病毒核心 (IBVC)
  • 批准号:
    10205988
  • 财政年份:
    2004
  • 资助金额:
    $ 22.09万
  • 项目类别:
Epithelial innate signaling in airway inflammation and remodeling
气道炎症和重塑中的上皮先天信号传导
  • 批准号:
    10205986
  • 财政年份:
    2004
  • 资助金额:
    $ 22.09万
  • 项目类别:

相似海外基金

Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 22.09万
  • 项目类别:
    Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 22.09万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 22.09万
  • 项目类别:
    Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 22.09万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 22.09万
  • 项目类别:
    Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 22.09万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 22.09万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 22.09万
  • 项目类别:
    Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 22.09万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
  • 批准号:
    2244994
  • 财政年份:
    2023
  • 资助金额:
    $ 22.09万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了